title: Altered response to meta-chlorophenylpiperazine in anorexia nervosa: support for a persistent alteration of serotonin activity after short-term weight restoration.
abstract: OBJECTIVE
  Patients with anorexia nervosa (AN) have disturbances of appetite and behaviors, such as dysphoria, inhibition, and obsessions, that could be related to altered serotonin activity. To investigate such relationships, we administered meta-chlorophenylpiperazine (m-CPP), a relatively serotonin-specific drug.
  
  
  METHODS
  To avoid the confounding effects of malnutrition or weight loss, we studied 12 patients with restricting-type AN between 5 and 17 days after a return to a normal weight and while on a stable dietary intake. We compared them to 12 healthy control women (CW). m-CPP was administered double blind and placebo controlled.
  
  
  RESULTS
  Although weight restored, AN women had lower body weight and increased ratings for depression and obsessionality compared with CW. After m-CPP, AN women had an elevation in mood and a reduction in body image distortion when compared with placebo. After m-CPP, groups had similar cortisol, adrenocorticotropin (ACTH), and growth hormone responses whereas AN women had an uncertain reduction in prolactin response.
  
  
  CONCLUSIONS
  These data support other studies that suggest that altered serotonin activity persists after weight restoration in AN patients. The finding that m-CPP temporarily improved mood and reduced body image distortions supports the hypothesis that altered serotonin activity may contribute to the pathophysiology of AN.
authors: University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
authors: G K
authors: GK
authors: Frank
authors: W H
authors: WH
authors: Kaye
authors: T E
authors: TE
authors: Weltzin
authors: J
authors: J
authors: Perel
authors: H
authors: H
authors: Moss
authors: C
authors: C
authors: McConaha
authors: C
authors: C
authors: Pollice
mesh_terms: D000293:Adolescent; D000328:Adult; D000339:Affect / Q000187:drug effects*; D000856:Anorexia Nervosa / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D001828:Body Image; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D010879:Piperazines / Q000494:pharmacology*; D012701:Serotonin / Q000494:pharmacology*; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*; D015430:Weight Gain
chemical_list: D010879:Piperazines; D017366:Serotonin Receptor Agonists; D012701:Serotonin; C015068:1-(3-chlorophenyl)piperazine